Literature DB >> 30549433

Lethal thrombocytopenia in a patient treated with avelumab for metastatic Merkel cell carcinoma.

Dorothea Kratzsch1, Jan-Christoph Simon1, Iris Pönitzsch1, Mirjana Ziemer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30549433     DOI： 10.1111/ddg.13722

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  3 in total

Review 1.  Severe Thrombocytopenia Associated With Pembrolizumab in Patients With Non-small Cell Lung Cancer (NSCLC): A Case Report and Literature Review.

Authors:  Atsuto Mouri; Kyoichi Kaira; Ayako Shiono; Y U Miura; Hiroshi Kagamu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 2.  Immune checkpoint inhibitors to treat cutaneous malignancies.

Authors:  Dulce M Barrios; Mytrang H Do; Gregory S Phillips; Michael A Postow; Tomoko Akaike; Paul Nghiem; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-24       Impact factor: 11.527

3.  Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Nabil E Omar; Kareem A El-Fass; Abdelrahman I Abushouk; Noha Elbaghdady; Abd Elmonem M Barakat; Ahmed E Noreldin; Dina Johar; Mohamed Yassin; Anas Hamad; Shereen Elazzazy; Said Dermime
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.